ID

39267

Beschreibung

Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01599104

Link

https://clinicaltrials.gov/show/NCT01599104

Stichworte

Versionen (1)
  1. 14.12.19 14.12.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

14. Dezember 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Essential Hypertension NCT01599104

Englisch

Eligibility Essential Hypertension NCT01599104

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with mild-to-moderate hypertension, untreated or currently taking antihypertensive therapy.
Beschreibung

Mild hypertension untreated | Moderate hypertension untreated | Hypertension, mild | Hypertension, moderate | Antihypertensive therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3276943
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C1969581
UMLS CUI [2,2]
C0332155
UMLS CUI [3]
C3276943
UMLS CUI [4]
C1969581
UMLS CUI [5]
C0585941
treated patients (using antihypertensive treatments within 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at the randomization visit (visit 201) and mssbp ≥140 mmhg < 180 mmhg at the visit immediately proceeding visit 201 (visit 102 or 103).
Beschreibung

Patients Treated | Antihypertensive therapy | Sitting systolic blood pressure mean | Randomization Visit | Visit preceding

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1522326
UMLS CUI [2]
C0585941
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
UMLS CUI [4,1]
C0034656
UMLS CUI [4,2]
C0008952
UMLS CUI [5,1]
C0008952
UMLS CUI [5,2]
C0332152
untreated patients (newly diagnosed with essential hypertension or having a history of hypertension but have not been taking any antihypertensive drugs for at least 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at both visit 1 and visit 201.
Beschreibung

Patients untreated | Essential Hypertension Newly Diagnosed | History of hypertension | Sitting systolic blood pressure mean

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0332155
UMLS CUI [2,1]
C0085580
UMLS CUI [2,2]
C1518321
UMLS CUI [3]
C0455527
UMLS CUI [4,1]
C1319893
UMLS CUI [4,2]
C0444504
patients must have an absolute difference of ≤15 mmhg in mssbp between visit 201 and the immediately preceding visit;
Beschreibung

Difference Sitting systolic blood pressure mean | Randomization Visit | Visit preceding

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1705242
UMLS CUI [1,2]
C1319893
UMLS CUI [1,3]
C0444504
UMLS CUI [2,1]
C0034656
UMLS CUI [2,2]
C0008952
UMLS CUI [3,1]
C0008952
UMLS CUI [3,2]
C0332152
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
severe hypertension (msdbp ≥110 mmhg and/or mssbp ≥ 180 mmhg).
Beschreibung

Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean

Datentyp

boolean

Alias
UMLS CUI [1]
C4013784
UMLS CUI [2,1]
C1319894
UMLS CUI [2,2]
C0444504
UMLS CUI [3,1]
C1319893
UMLS CUI [3,2]
C0444504
history of angioedema, drug-related or otherwise, as reported by the patient.
Beschreibung

Angioedema Drug-induced | Angioedema

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0002994
UMLS CUI [1,2]
C0458082
UMLS CUI [2]
C0002994
history or evidence of a secondary form of hypertension, including but not limited to any of the following: renal parenchymal hypertension, renovascular hypertension (unilateral or bilateral renal artery stenosis), coarctation of the aorta, primary hyperaldosteronism, cushing's disease, pheochromocytoma, polycystic kidney disease, and drug-induced hypertension.
Beschreibung

Secondary hypertension | Parenchymal renal hypertension | Hypertension, Renovascular | Unilateral renal artery stenosis | Bilateral renal artery stenosis | Aortic coarctation | Conn Syndrome | Cushing's disease | Pheochromocytoma | Polycystic Kidney Diseases | Hypertensive disease Drug-induced

Datentyp

boolean

Alias
UMLS CUI [1]
C0155616
UMLS CUI [2]
C0264649
UMLS CUI [3]
C0020545
UMLS CUI [4]
C0856759
UMLS CUI [5]
C0856760
UMLS CUI [6]
C0003492
UMLS CUI [7]
C1384514
UMLS CUI [8]
C0221406
UMLS CUI [9]
C0031511
UMLS CUI [10]
C0022680
UMLS CUI [11,1]
C0020538
UMLS CUI [11,2]
C0458082
patients who previously entered a lcz696 study and had been randomized or enrolled into the active drug treatment epoch.
Beschreibung

Study Subject Participation Status | LCZ 696 Clinical Trial

Datentyp

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2,1]
C2933615
UMLS CUI [2,2]
C0008976
other protocol-defined inclusion/exclusion criteria may apply.
Beschreibung

Eligibility Criteria Study Protocol

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Essential Hypertension NCT01599104

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Mild hypertension untreated | Moderate hypertension untreated | Hypertension, mild | Hypertension, moderate | Antihypertensive therapy
Item
patients with mild-to-moderate hypertension, untreated or currently taking antihypertensive therapy.
boolean
C3276943 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C1969581 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
C3276943 (UMLS CUI [3])
C1969581 (UMLS CUI [4])
C0585941 (UMLS CUI [5])
Patients Treated | Antihypertensive therapy | Sitting systolic blood pressure mean | Randomization Visit | Visit preceding
Item
treated patients (using antihypertensive treatments within 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at the randomization visit (visit 201) and mssbp ≥140 mmhg < 180 mmhg at the visit immediately proceeding visit 201 (visit 102 or 103).
boolean
C0030705 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
C0585941 (UMLS CUI [2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
C0034656 (UMLS CUI [4,1])
C0008952 (UMLS CUI [4,2])
C0008952 (UMLS CUI [5,1])
C0332152 (UMLS CUI [5,2])
Patients untreated | Essential Hypertension Newly Diagnosed | History of hypertension | Sitting systolic blood pressure mean
Item
untreated patients (newly diagnosed with essential hypertension or having a history of hypertension but have not been taking any antihypertensive drugs for at least 4 weeks prior to visit 1) must have an mssbp ≥ 150 mmhg and < 180 mmhg at both visit 1 and visit 201.
boolean
C0030705 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0085580 (UMLS CUI [2,1])
C1518321 (UMLS CUI [2,2])
C0455527 (UMLS CUI [3])
C1319893 (UMLS CUI [4,1])
C0444504 (UMLS CUI [4,2])
Difference Sitting systolic blood pressure mean | Randomization Visit | Visit preceding
Item
patients must have an absolute difference of ≤15 mmhg in mssbp between visit 201 and the immediately preceding visit;
boolean
C1705242 (UMLS CUI [1,1])
C1319893 (UMLS CUI [1,2])
C0444504 (UMLS CUI [1,3])
C0034656 (UMLS CUI [2,1])
C0008952 (UMLS CUI [2,2])
C0008952 (UMLS CUI [3,1])
C0332152 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hypertension, severe | Sitting diastolic blood pressure mean | Sitting systolic blood pressure mean
Item
severe hypertension (msdbp ≥110 mmhg and/or mssbp ≥ 180 mmhg).
boolean
C4013784 (UMLS CUI [1])
C1319894 (UMLS CUI [2,1])
C0444504 (UMLS CUI [2,2])
C1319893 (UMLS CUI [3,1])
C0444504 (UMLS CUI [3,2])
Angioedema Drug-induced | Angioedema
Item
history of angioedema, drug-related or otherwise, as reported by the patient.
boolean
C0002994 (UMLS CUI [1,1])
C0458082 (UMLS CUI [1,2])
C0002994 (UMLS CUI [2])
Secondary hypertension | Parenchymal renal hypertension | Hypertension, Renovascular | Unilateral renal artery stenosis | Bilateral renal artery stenosis | Aortic coarctation | Conn Syndrome | Cushing's disease | Pheochromocytoma | Polycystic Kidney Diseases | Hypertensive disease Drug-induced
Item
history or evidence of a secondary form of hypertension, including but not limited to any of the following: renal parenchymal hypertension, renovascular hypertension (unilateral or bilateral renal artery stenosis), coarctation of the aorta, primary hyperaldosteronism, cushing's disease, pheochromocytoma, polycystic kidney disease, and drug-induced hypertension.
boolean
C0155616 (UMLS CUI [1])
C0264649 (UMLS CUI [2])
C0020545 (UMLS CUI [3])
C0856759 (UMLS CUI [4])
C0856760 (UMLS CUI [5])
C0003492 (UMLS CUI [6])
C1384514 (UMLS CUI [7])
C0221406 (UMLS CUI [8])
C0031511 (UMLS CUI [9])
C0022680 (UMLS CUI [10])
C0020538 (UMLS CUI [11,1])
C0458082 (UMLS CUI [11,2])
Study Subject Participation Status | LCZ 696 Clinical Trial
Item
patients who previously entered a lcz696 study and had been randomized or enrolled into the active drug treatment epoch.
boolean
C2348568 (UMLS CUI [1])
C2933615 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply.
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video